Biomarin Pharmaceutical Inc (BMRN)
65.60
-1.06
(-1.59%)
USD |
NASDAQ |
Nov 14, 16:00
65.58
-0.02
(-0.03%)
After-Hours: 20:00
Biomarin Pharmaceutical Cash and Short Term Investments (Quarterly): 930.44M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 930.44M |
| June 30, 2024 | 1.224B |
| March 31, 2024 | 1.047B |
| December 31, 2023 | 1.074B |
| September 30, 2023 | 1.126B |
| June 30, 2023 | 1.171B |
| March 31, 2023 | 1.152B |
| December 31, 2022 | 1.292B |
| September 30, 2022 | 1.274B |
| June 30, 2022 | 1.110B |
| March 31, 2022 | 1.056B |
| December 31, 2021 | 1.014B |
| September 30, 2021 | 1.079B |
| June 30, 2021 | 1.123B |
| March 31, 2021 | 1.087B |
| December 31, 2020 | 1.065B |
| September 30, 2020 | 1.506B |
| June 30, 2020 | 1.380B |
| March 31, 2020 | 858.40M |
| December 31, 2019 | 753.81M |
| September 30, 2019 | 720.79M |
| June 30, 2019 | 731.10M |
| March 31, 2019 | 894.85M |
| December 31, 2018 | 1.084B |
| September 30, 2018 | 1.443B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.363B |
| March 31, 2018 | 1.383B |
| December 31, 2017 | 1.396B |
| September 30, 2017 | 1.257B |
| June 30, 2017 | 727.78M |
| March 31, 2017 | 678.06M |
| December 31, 2016 | 789.68M |
| September 30, 2016 | 1.035B |
| June 30, 2016 | 503.29M |
| March 31, 2016 | 456.85M |
| December 31, 2015 | 592.62M |
| September 30, 2015 | 618.33M |
| June 30, 2015 | 681.55M |
| March 31, 2015 | 1.009B |
| December 31, 2014 | 945.19M |
| September 30, 2014 | 666.37M |
| June 30, 2014 | 836.62M |
| March 31, 2014 | 887.48M |
| December 31, 2013 | 784.72M |
| September 30, 2013 | 379.65M |
| June 30, 2013 | 400.56M |
| March 31, 2013 | 401.88M |
| December 31, 2012 | 447.80M |
| September 30, 2012 | 426.46M |
| June 30, 2012 | 402.59M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
753.81M
Minimum
Dec 2019
1.506B
Maximum
Sep 2020
1.116B
Average
1.099B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Merck & Co Inc | 14.59B |
| Bristol-Myers Squibb Co | 8.094B |
| Alnylam Pharmaceuticals Inc | 2.780B |
| Repligen Corp | 809.15M |
| Bioventus Inc | 43.07M |